Literature DB >> 11261515

Children with comorbid attention-deficit-hyperactivity disorder and tic disorder: evidence for additive inhibitory deficits within the motor system.

G H Moll1, H Heinrich, G E Trott, S Wirth, N Bock, A Rothenberger.   

Abstract

For children with attention-deficit-hyperactivity disorder (ADHD) or tic disorder (TD), we recently reported deficient inhibitory mechanisms within the motor system by using transcranial magnetic stimulation. These deficits--stated as reduced intracortical inhibition in ADHD and shortened cortical silent period in TD--could be seen as neurophysiological correlates of motor hyperactivity and tics, respectively. To investigate neurophysiological aspects of comorbidity, we measured motor system excitability for the first time also in children with combined ADHD and TD. The findings of a reduced intracortical inhibition as well as a shortened cortical silent period in these comorbid children provide evidence for additive effects at the level of motor system excitability.

Entities:  

Mesh:

Year:  2001        PMID: 11261515

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  34 in total

1.  Psychopathological profile in children with chronic tic disorder and co-existing ADHD: additive effects.

Authors:  Veit Roessner; Andreas Becker; Tobias Banaschewski; Aribert Rothenberger
Journal:  J Abnorm Child Psychol       Date:  2006-12-15

2.  Reduced short interval cortical inhibition correlates with atomoxetine response in children with attention-deficit hyperactivity disorder (ADHD).

Authors:  Tina H Chen; Steve W Wu; Jeffrey A Welge; Stephan G Dixon; Nasrin Shahana; David A Huddleston; Adam R Sarvis; Floyd R Sallee; Donald L Gilbert
Journal:  J Child Neurol       Date:  2014-01-10       Impact factor: 1.987

Review 3.  Co-existing disorders in ADHD -- implications for diagnosis and intervention.

Authors:  Christopher Gillberg; I Carina Gillberg; Peder Rasmussen; Björn Kadesjö; Henrik Söderström; Mania Råstam; Mato Johnson; Aribert Rothenberger; Lena Niklasson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

4.  Transcranial magnetic stimulation measures in attention-deficit/hyperactivity disorder.

Authors:  Steve W Wu; Donald L Gilbert; Nasrin Shahana; David A Huddleston; Stewart H Mostofsky
Journal:  Pediatr Neurol       Date:  2012-09       Impact factor: 3.372

5.  Color perception deficits in co-existing attention-deficit/hyperactivity disorder and chronic tic disorders.

Authors:  V Roessner; T Banaschewski; A Fillmer-Otte; A Becker; B Albrecht; H Uebel; J Sergeant; R Tannock; A Rothenberger
Journal:  J Neural Transm (Vienna)       Date:  2007-09-27       Impact factor: 3.575

6.  Attentional functions in children and adolescents with attention-deficit/hyperactivity disorder with and without comorbid tic disorder.

Authors:  E Greimel; B Herpertz-Dahlmann; T Günther; C Vitt; K Konrad
Journal:  J Neural Transm (Vienna)       Date:  2007-09-25       Impact factor: 3.575

7.  Executive and attention functioning among children in the PANDAS subgroup.

Authors:  Matthew E Hirschtritt; Christopher J Hammond; David Luckenbaugh; Jason Buhle; Audrey E Thurm; B J Casey; Susan E Swedo
Journal:  Child Neuropsychol       Date:  2008-07-11       Impact factor: 2.500

8.  Modulation of human motor cortex excitability by quetiapine.

Authors:  Berthold Langguth; Peter Eichhammer; Claus Spranz; Michael Landgrebe; Ulrich Frick; Philipp Sand; Göran Hajak
Journal:  Psychopharmacology (Berl)       Date:  2007-11-23       Impact factor: 4.530

9.  Executive functions in children with chronic tic disorders with/without ADHD: new insights.

Authors:  Veit Roessner; Andreas Becker; Tobias Banaschewski; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

Review 10.  Comorbidity of tic disorders & ADHD: conceptual and methodological considerations.

Authors:  Tobias Banaschewski; Benjamin M Neale; Aribert Rothenberger; Veit Roessner
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.